论文信息 - Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. - 字舞流文

Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma.

L. Schwartz | R. Motzer | J. Bacik | T. Mariani | M. Mazumdar | D. Cella | D. Fairclough | G. Wilding | B. Murphy | D. Nanus | P. Loehrer